Search Results - "TP53"

Prognostic and predictive factors in gynecologic cancers

Table of Contents: “…Clinical predictors of outcome in epithelial ovarian carcinoma -- Influence of BRCA1 and BRCA2 on ovarian cancer survival -- Cell cycle and apoptotic markers -- TP53/p53 as a prognostic factor -- Molecular profiling in ovarian cancer -- Angiogenesis and epithelial ovarian carcinoma -- Cell adehsion and matrix-associated proteins in ovarian carcinoma -- Immune biomarkers in ovarian cancer -- Predictive factors in germ cell and stromal tumors -- Rethinking traditional surgical-pathologic criteria for early endometrial cancer: studies of patterns of failure -- Molecular prognostic and predictive factors in advanced endometrial cancer: implications for therapy -- Endometrial cancer associated with defective DNA mismatch repair -- Molecular profiling in endometrial cancer: current research and implications for the future -- Prognostic markers of uterine papillary serous carcinoma -- Predictors of outcome in malignant mixed müllerian tumors of the uterus -- Clinical-pathologic predictors in patients with cervical cancer -- Predictors of radiation sensitivity and resistance -- Molecular prognostic and predictive factors in cervical cancer -- Virology in the prevention and management of cervical cancer -- Molecular imaging of cervical cancer -- Neuroendocrine cancer of the cervix: prognostic and predictive factors -- Predictive values of sentinel lymph nodes.…”
Click Here to View Status and Holdings.

Central nervous system tumours

Table of Contents: “…H3 G34-mutant g| p. 74 -- t| Diffuse paediatric-type high-grade glioma, H3-wildtype and IDH-wildtype g| p. 77 -- t| Infant-type hemispheric glioma g| p. 81 -- t| Circumscribed astrocytic gliomas -- t| Piiocytic astrocytoma g| p. 83 -- t| High-grade astrocytoma with piloid features g| p. 90 -- t| Pleomorphic xanthoastrocytoma g| p. 94 -- t| Subependymal giant cell astrocytoma g| p. 100 -- t| Chordoid glioma g| p. 104 -- t| Astroblastoma, MN1-altered g| p. 107 -- t| Glioneuronal and neuronal tumours -- t| Ganglioglioma g| p. 111 -- t| Gangliocytoma g| p. 116 -- t| Desmoplastic infantile ganglioglioma / desmoplastic infantile astrocytoma g| p. 119 -- t| Dysembryoplastic neuroepithelial tumour g| p. 123 -- t| Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters g| p. 127 -- t| Papillary glioneuronal tumour g| p. 130 -- t| Rosette-forming glioneuronal tumour g| p. 133 -- t| Myxoid glioneuronal tumour g| p. 136 -- t| Diffuse leptomemngeal glioneuronal tumour g| p. 139 -- t| Multinodular and vacuolating neuronal tumour g| p. 143 -- t| Dysplastic cerebellar gangliocytoma (Lhermitte-Duclos disease) g| p. 146 -- t| Central neurocytoma g| p. 149 -- t| Extraventricular neurocytoma g| p. 153 -- t| Cerebellar liponeurocytoma g| p. 156 -- t| Ependymal tumours -- t| Supratentorial ependymoma g| p. 161 -- t| Supratentorial ependymoma, ZFTA fusion-positive g| p. 164 -- t| Supratentorial ependymoma, YAP1 fusion-positive g| p. 167 -- t| Posterior fossa ependymoma g| p. 169 -- t| Posterior fossa group A (PFA) ependymoma g| p. 172 -- t| Posterior fossa group B (PFB) ependymoma g| p. 175 -- t| Spinal ependymoma g| p. 177 -- t| Spinal ependymoma, MYCN-amplified g| p. 180 -- t| Myxopapillary ependymoma g| p. 183 -- t| Subependymoma g| p. 186 -- g| 3 t| Choroid plexus tumours g| p. 189 -- t| Choroid plexus papilloma g| p. 190 -- t| Atypical choroid plexus papilloma g| p. 193 -- t| Choroid plexus carcinoma g| p. 195 -- g| 4 t| Embryonal tumours g| p. 199 -- t| Medulloblastoma -- t| Medulloblastomas, molecularly defined -- t| Medulloblastoma, WNT-activated g| p. 203 -- t| Medulloblastoma, SHH-activated and TP53-wildtype g| p. 205 -- t| Medulloblastoma, SHH-activated and TP53-mutant g| p. 208 -- t| Medulloblastoma, non-WNT/non-SHH g| p. 211 -- t| Medulloblastomas, histologically defined Medulloblastoma, histologically defined g| p. 213 -- t| Other CNS embryonal tumours -- t| Atypical teratoid/rhabdoid tumour g| p. 221 -- t| Cribriform neuroepithelial tumour g| p. 226 -- t| Embryonal tumour with multilayered rosettes g| p. 228 -- t| CNS neuroblastoma, FOXR2-activated g| p. 232 -- t| CNS tumour with BCOR internal tandem duplication g| p. 235 -- t| CNS embryonal tumour NEC/NOS g| p. 238 -- g| 5 t| Pineal tumours g| p. 241 -- t| Pineocytoma g| p. 243 -- t| Pineal parenchymal tumour of intermediate differentiation g| p. 246 -- t| Pineoblastoma g| p. 249 -- t| Papillary tumour of the pineal region g| p. 253 -- t| Desmoplastic myxoid tumour of the pineal region, SMARCB1-mutant g| p. 256 -- g| 6 t| Cranial and paraspinal nerve tumours g| p. 259 -- t| Schwannoma g| p. 261 -- t| Neurofibroma g| p. 265 -- t| Perineurioma g| p. 269 -- t| Hybrid nerve sheath tumours g| p. 271 -- t| Malignant melanotic nerve sheath tumour g| p. 273 -- t| Malignant peripheral nerve sheath tumour g| p. 275 -- t| Cauda equina neuroendocrine tumour (previously paraganglioma) g| p. 279 -- g| 7 t| Meningioma g| p. 283 -- g| 8 t| Mesenchymal, non-meningothelial tumours involving the CNS g| p. 299 -- t| Soft tissue tumours -- t| Fibroblastic and myofibroblastic tumours -- t| Solitary fibrous tumour g| p. 301 -- t| Vascular tumours -- t| Haemangiomas and vascular malformations g| p. 306 -- t| Haemangioblastoma g| p. 310 -- t| Skeletal muscle tumours -- t| Rhabdomyosarcoma g| p. 314 -- t| Tumours of uncertain differentiation -- t| Intracranial mesenchymal tumour, FET::CREB fusion-positive g| p. 317 -- t| CIC-rearranged sarcoma g| p. 320 -- t| Primary intracranial sarcoma, DICER1-mutant g| p. 323 -- t| Ewing sarcoma g| p. 326 -- t| Chondro-osseous tumours -- t| Chondrogenic tumours -- t| Mesenchymal chondrosarcoma g| p. 330 -- t| Chondrosarcoma g| p. 332 -- t| Notochordal tumours -- t| Chordoma g| p. 335 -- g| 9 t| Melanocytic tumours g| p. 339 -- t| Diffuse meningeal melanocytic neoplasms -- t| Melanocytosis and melanomatosis g| p. 341 -- t| Circumscribed meningeal melanocytic neoplasms -- t| Melanocytoma and melanoma g| p. 344 -- g| 10 t| Haematolymphoid tumours involving the CNS g| p. 349 -- t| Lymphomas -- t| CNS lymphomas -- t| Primary diffuse large B-cell lymphoma of the CNS g| p. 351 -- t| Immunodeficiency-associated CNS lymphomas g| p. 356 -- t| Lymphomatoid granulomatosis g| p. 358 -- t| Intravascular large B-cell lymphoma g| p. 360 -- t| Miscellaneous rare lymphomas in the CNS -- t| MALT lymphoma of the dura g| p. 362 -- t| Other low-grade B-cell lymphomas of the CNS g| p. 364 -- t| Anaplastic large cell lymphoma (ALK+/ALK-) g| p. 366 -- t| T-cell and NK/T-cell lymphomas g| p. 368 -- t| Histiocytic tumours -- t| Erdheim-Chester disease g| p. 370 -- t| Rosai-Dorfman disease g| p. 372 -- t| Juvenile xanthogranuloma g| p. 374 -- t| Langerhans cell histiocytosis g| p. 376 -- t| Histiocytic sarcoma g| p. 379 -- g| 11 t| Germ cell tumours g| p. 381 -- g| 12 t| Tumours of the sellar region g| p. 391 -- t| Adamantinomatous craniopharyngioma g| p. 393 -- t| Papillary craniopharyngioma g| p. 397 -- t| Pituicytoma, granular cell tumour of the sellar region, and spindle cell oncocytoma g| p. 401 -- t| Pituitary adenoma / pituitary neuroendocrine tumour g| p. 406 -- t| Pituitary blastoma g| p. 415 -- g| 13 t| Metastases to the CNS g| p. 417 -- t| Metastases to the brain and spinal cord parenchyma g| p. 418 -- t| Metastases to the meninges g| p. 421 -- g| 14 t| Genetic tumour syndromes involving the CNS g| p. 423 -- t| Neurofibromatosis type 1 g| p. 426 -- t| Neurofibromatosis type 2 g| p. 429 -- t| Schwannomatosis g| p. 434 -- t| Von Hippel-Lindau syndrome g| p. 437 -- t| Tuberous sclerosis g| p. 441 -- t| Li-Fraumeni syndrome g| p. 446 -- t| Cowden syndrome g| p. 449 -- t| Constitutional mismatch repair deficiency syndrome g| p. 452 -- t| Familial adenomatous polyposis 1 g| p. 456 -- t| Naevoid basal cell carcinoma syndrome g| p. 458 -- t| Rhabdoid tumour predisposition syndrome g| p. 460 -- t| Carney complex g| p. 462 -- t| DICER1 syndrome g| p. 464 -- t| Familial paraganglioma syndromes g| p. 467 -- t| Melanoma-astrocytoma syndrome g| p. 471 -- t| Familial retinoblastoma g| p. 473 -- t| BAP1 tumour predisposition syndrome g| p. 475 -- t| Fanconi anaemia g| p. 478 -- t| ELP1-medulloblastoma syndrome…”
Click Here to View Status and Holdings.